CytoDyn Inc.
CYDY
$0.25
-$0.01-2.40%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -172.75% | -10.39% | 107.51% | 86.29% | 73.35% |
| Total Depreciation and Amortization | -10.00% | -29.17% | -37.93% | -48.57% | -50.00% |
| Total Amortization of Deferred Charges | -82.67% | -72.00% | -75.30% | -75.69% | -49.11% |
| Total Other Non-Cash Items | -93.30% | -94.60% | -87.32% | -57.42% | -35.88% |
| Change in Net Operating Assets | 352.83% | 145.93% | -238.72% | -229.85% | -251.51% |
| Cash from Operations | -717.41% | -1,490.74% | 20.19% | 62.71% | 87.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -53.51% |
| Total Debt Repaid | 80.00% | 80.00% | -- | -- | -- |
| Issuance of Common Stock | -80.26% | -81.59% | -87.42% | -52.94% | -66.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | -- | 129,812.50% | 1,439.61% |
| Cash from Financing | -93.63% | -93.87% | -7.61% | 35.95% | -19.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -211.92% | -195.35% | 172.72% | 371.36% | 254.55% |